|
The Pharmaceutical Journal |
|
News summary |
Numark's risk-free trialNumark is to allow its shareholders to order its top own-label products on a trial sale or return basis to overcome shareholder reluctance to try the products in their pharmacies. |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal